BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib

Marco Ranzani, Constantine Alifrangis, Daniele Perna, Ken Dutton-Regester, Antonia Pritchard, Kim Wong, Mamunur Rashid, Carla Daniela Robles-Espinoza, Nicholas K. Hayward, Ultan McDermott, Mathew Garnett, David J. Adams

Research output: Contribution to journalArticle

26 Citations (Scopus)
Original languageEnglish
Pages (from-to)117-119
Number of pages3
JournalPigment Cell and Melanoma Research
Volume28
Issue number1
Early online date13 Oct 2014
DOIs
Publication statusPublished - Jan 2015

Cite this

Ranzani, M., Alifrangis, C., Perna, D., Dutton-Regester, K., Pritchard, A., Wong, K., Rashid, M., Robles-Espinoza, C. D., Hayward, N. K., McDermott, U., Garnett, M., & Adams, D. J. (2015). BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib. Pigment Cell and Melanoma Research, 28(1), 117-119. https://doi.org/10.1111/pcmr.12316